Introduction
============

Pancreatic ductal adenocarcinoma (PDAC) is a life-threatening malignant neoplasm which may invade and metastasize at an early stage ([@b1-ol-0-0-8147]). The deoxycytidine analogue gemcitabine \[2′,2′-difluorodeoxycytidine (dFdC)\] remains the standard of care for disseminated PDAC, prolonging the survival time by \>5 weeks in a minority of patients ([@b2-ol-0-0-8147]). Gemcitabine-based combination therapies may offer a survival benefit by decreasing the progression of PDAC ([@b3-ol-0-0-8147]). A previous study has identified that targeted inhibition of the epidermal growth factor receptor with erlotinib increases the median survival time by 2 weeks ([@b4-ol-0-0-8147]). PDAC exhibits a poor response to chemotherapy; therefore, the identification of an effective therapy for treating advanced PDAC is required.

Hyaluronan (HA) is synthesized by three types of HA synthase (HAS) termed HAS1, HAS2 and HAS3 ([@b5-ol-0-0-8147]). HA is synthesized in distinct amounts and sizes, depending on the type of synthase: HAS1 and HAS2 synthesize low and high (in the range of millions of Da) amounts of high-molecular-weight HA (HMW-HA), respectively, whereas HAS3 produces high amounts of low-molecular-weight HA (LMW-HA), in the range of several thousands of Da ([@b6-ol-0-0-8147]). The size of HA may vary between 20 kDa and 10 MDa, and, depending on the size, extracellular HA regulates a number of cellular biological functions, including cell motility, tumor viability, migration, metastasis, chemotherapeutic resistance and cytokine production, via direct interactions with cell-surface receptors ([@b7-ol-0-0-8147]--[@b9-ol-0-0-8147]). A number of human PDAC cell lines synthesize and secrete HA ([@b10-ol-0-0-8147]), and the highest distribution of HA between the tumor mass and the normal tissue is exhibited in human primary pancreatic carcinomas, suggesting that HA may promote tumor invasion and form a barrier for cancer cells against host immunocompetent cells and anticancer agents ([@b11-ol-0-0-8147]--[@b14-ol-0-0-8147]). A previous study revealed the association between increased expression of HA and poor prognosis in pancreatic cancer ([@b15-ol-0-0-8147]). Therefore, inhibiting HA synthesis to control tumor invasion and drug resistance, and subsequently to improve prognosis in patients with PDAC is required.

4-Methylumbelliferone (4-MU; 7-hydroxy-4-methylcoumarin) has been identified to be an inhibitor of HA synthesis in a number of previous studies ([@b16-ol-0-0-8147]--[@b28-ol-0-0-8147]). In particular, the inhibitory effect of 4-MU on HA synthesis demonstrates anticancer effects through decreasing cell viability, adhesion, migration and invasion ([@b19-ol-0-0-8147],[@b25-ol-0-0-8147]--[@b28-ol-0-0-8147]), and increasing the efficacy of anticancer agents ([@b23-ol-0-0-8147]). The mechanisms that enable 4-MU to inhibit HA synthesis remain unclear. It has been hypothesized that 4-MU inhibits HA synthesis via glucuronidation by endogenous uridine phosphate (UDP)-glucuronosyltransferase (UGT), which results in the depletion of UDP-glucuronic acid (UDP-GlcUA) ([@b20-ol-0-0-8147]), and a decrease in HAS mRNA levels ([@b24-ol-0-0-8147],[@b25-ol-0-0-8147]). In addition, previous studies have identified that 4-MU decreases the expression of a number of matrix metalloproteinases ([@b29-ol-0-0-8147],[@b30-ol-0-0-8147]) and cell-adhesion molecules ([@b31-ol-0-0-8147]), alters phosphorylation of intracellular proteins ([@b26-ol-0-0-8147],[@b32-ol-0-0-8147],[@b33-ol-0-0-8147]) and increases levels of UGT1 enzymes, leading to decreased UDP-GlcUA levels ([@b24-ol-0-0-8147]).

The present study aimed at investigating whether the interaction between PDAC cells and fibroblasts may increase HA production and cell migration. Furthermore, whether 4-MU may decrease the migration of PDAC cells in co-culture with fibroblasts was investigated.

Materials and methods
=====================

### Cell lines and reagents

The Panc-1 cell line was purchased from the American Type Culture Collection (Manassas, VA, USA). Primary fibroblasts derived from PDAC tissues were a gift from Kyushu University (Fukuoka, Japan). All the cell lines were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (all from Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37°C in a humidified atmosphere containing 5% CO~2~. 4-MU was purchased from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany).

### ELISA determination of HA concentrations

HA concentrations in cell culture media were determined according to a previous protocol ([@b15-ol-0-0-8147]). The quantity of HA was expressed per ml.

### Migration assay

Panc-1 cells (2×10^5^ cells/ml) in 250 µl serum-free RPMI-1640 medium were seeded to the upper chamber (24-well insert, 8 µm pore size; BD Biosciences, Franklin Lakes, NJ, USA). A total of 750 µl serum-free RPMI-1640 medium was added to the lower chamber as a monoculture. Primary fibroblasts (ike-f3 cells) in 750 µl serum-free RPMI-1640 medium were seeded (1×10^5^ cells/ml) in the lower chamber as a co-culture without or with various concentrations (10, 100 and 1,000 µM) of 4-MU for 72 h. Additionally, 7.5×10^4^ cells/ml ike-f3 cells were seeded in serum-free RPMI-1640 medium into the lower chamber for 72 h as a fibroblast monoculture. The supernatant fractions of monoculture and co-culture were divided into aliquots and stored at −80°C until use. Non-migrating cells on the upper surface of the membrane were removed with a cotton swab. Migrating cells penetrated onto the lower surface of the membrane and were fixed with 70% methanol, stained with hematoxylin (at room temperature for 10 min) and eosin (at room temperature, between 5--10 min) and air-dried. The number of migrating cells was determined in 6 randomly selected fields at ×400 magnification by light microscope. Subsequently, the average number of cells per microscopic field was calculated as the extent of migration.

### Co-culture system

Panc-1 cells (2×10^5^ cells/ml) in serum-free medium were seeded in the upper chamber (High Density, Translucent PET Membrane 6-well insert, 0.4 µm pore size; BD Biosciences) and 3 ml serum-free medium was added into the lower chamber as a monoculture. Ike-f3 cells (1×10^5^ cells/ml) in 3 ml serum-free medium were seeded in the lower chamber as a co-culture for 72 h. All samples were used to extract RNA.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

mRNA expression analysis of *HAS1* (Hs00758053_m1), *HAS2* (Hs00193435_m1), *HAS3* (Hs00193436_m1) and *GAPDH* (Hs02758991_g1), as a control (Applied Biosystems; Thermo Fisher Scientific, Inc.), were performed (monoculture and co-culture), according to a previously described protocol ([@b34-ol-0-0-8147]).

### Trypan blue dye-exclusion assay cellular viability test

The effects of 4-MU (10, 100 and 1,000 µM) on cell viability were analyzed using trypan blue dye-exclusion (TBDE) assays as cytotoxic measurements. After 72 h at 37°C in a humidified atmosphere containing 5% CO~2~, the untreated and treated cells were harvested and stained with 4% trypan blue at room temperature and then counted by the LUNA™ automated cell counter (Logos Biosystems, Annandale, VA, USA) according to the manufacturer\'s protocol. Cytotoxicity was determined from the number of viable cells (no color) in treated samples as a percentage of the untreated control.

### Statistical analysis

Data were expressed as the mean ± standard deviation. All statistical analyses were performed using SPSS software (version 21.0; IBM Corp., Armonk, NY, USA). Differences in HA concentration and *HAS1, HAS2* and *HAS3* mRNA levels between monoculture and co-culture were compared using a paired Student\'s t-test. Comparisons between HA concentration and the migrating cell number, in all subgroups with various concentrations of 4-MU, were made using one-way analysis of variance and Fisher\'s least significant difference test. P\<0.05 indicated a statistically significant difference. All P-values were two-tailed and all investigations were repeated three times independently.

Results
=======

### Stimulation of HA production and cell migration in the co-culture system between human PDAC cells and fibroblasts

Co-culture of Panc-1 cells with fibroblasts resulted in a significant increase (P=0.016) in HA production, compared with those in monocultures ([Fig. 1A](#f1-ol-0-0-8147){ref-type="fig"}). In addition, the Transwell migration assay revealed that co-culture with fibroblasts significantly increased the migration of Panc-1 cells ([Fig. 1B](#f1-ol-0-0-8147){ref-type="fig"}).

To elucidate the mechanism of enhanced HA production by co-culture system, the mRNA expression levels of *HAS1, HAS2* and *HAS3* in Panc-1 cells and fibroblasts was investigated using RT-qPCR. The increased HA production was associated with a significantly increased mRNA expression of *HAS3*, but not *HAS1* and *HAS2* ([Fig. 2](#f2-ol-0-0-8147){ref-type="fig"}).

### Effects of 4-MU on HA biosynthesis and cell migration in the co-culture system

Panc-1 cells in the co-culture system were treated with various concentrations (10, 100 and 1,000 µM) of 4-MU. The results demonstrated that no marked effects on the cell viability were observed following treatment with the aforementioned range of 4-MU concentrations (data not shown). HA synthesis was inhibited by 88%, compared with the control, following treatment with 1,000 µM 4-MU; however, treatment with 10 and 100 µM revealed almost no alterations in HA production ([Fig. 3](#f3-ol-0-0-8147){ref-type="fig"}).

Panc-1 cell migration was evaluated using a Transwell migration assay ([Fig. 4A](#f4-ol-0-0-8147){ref-type="fig"}), which revealed that 4-MU inhibited Panc-1 cell migration in co-culture with fibroblasts. Inhibition of cell migration was observed at 10 µM and maximal inhibition was revealed to be at 1,000 µM ([Fig. 4B](#f4-ol-0-0-8147){ref-type="fig"}).

Discussion
==========

A previous study identified interactions between tumor cells and fibroblasts which stimulated HA synthesis and identified that HA is increased in tumors ([@b35-ol-0-0-8147]). In the present study, Panc-1 cells were co-cultured with fibroblasts which resulted in a marked increase in HA synthesis. Additionally, *HAS3* mRNA expression in Panc-1 cells and fibroblasts was significantly increased in this co-culture system. The results of the present study suggested that, for the first time, to the best of our knowledge, the increase in HA in a PDAC co-culture system was associated with markedly increased mRNA expression of *HAS3*. HAS3 may produce increased amounts of LMW-HA ([@b6-ol-0-0-8147]) and this contributes to tumor progression by increasing the motility of cancer cells ([@b36-ol-0-0-8147]--[@b38-ol-0-0-8147]). These interactions may explain why the co-culture system markedly increased PDAC cell migration.

HA production may be decreased by 4-MU via the depletion of cellular UDP-GlcUA and the downregulation of HAS2 and/or HAS3, and inhibit cell viability, migration and invasiveness ([@b25-ol-0-0-8147]). Therefore, PDAC cells in the co-culture system were treated with 4-MU. The results revealed a marked decrease in HA production and PDAC cell migration. This drug is promising because the safety of 4-MU for humans has already been confirmed. Oral 4-MU has been used to treat hepatobiliary disease due to the cholagogic and spasmolytic actions exhibited on the sphincter of Oddi ([@b39-ol-0-0-8147],[@b40-ol-0-0-8147]). The results of the present study demonstrated that the interaction between PDAC cells and fibroblasts stimulated HA production and PDAC cell migration, and 4-MU may inhibit HA synthesis and cell migration.
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![Alterations in HA production and pancreatic ductal adenocarcinoma cell migration in response to co-culture with fibroblasts. (A) ELISA demonstrating significantly increased HA production in co-culture system between Panc-1 cells and ike-f3 cells, compared with the sum of the incorporations by each cell line cultured alone (\*P\<0.05 vs. monocultures, paired Student\'s t-test). Results are presented as the mean ± standard deviation of three replicates. (B) Transwell migration assay (magnification, ×400) revealed that the co-culture system markedly increased the number of migrating Panc-1 cells. Results are presented as the mean ± standard deviation of six replicates. HA, hyaluronan.](ol-15-05-6297-g00){#f1-ol-0-0-8147}

![Alterations in *HAS1, HAS2* and *HAS3* mRNA expression levels in the co-culture system. *HAS3* mRNA expression was significantly increased in Panc-1 cells (P=0.049) and ike-f3 cells (P=0.044), compared with monoculture. Results are presented as the mean ± standard deviation of three replicates. HAS, hyaluronan synthase; RQ, relative quality.](ol-15-05-6297-g01){#f2-ol-0-0-8147}

![HA concentration in the co-culture system following treatment with 4-MU. HA synthesis was significantly decreased following treatment with 1,000 µM 4-MU, but was essentially unchanged at 10 and 100 µM (\*\*\*P\<0.001, one-way analysis of variance and Fisher\'s least significant difference test). Results are presented as the mean ± standard deviation of three replicates. HA, hyaluronan; 4-MU, 4-methylumbelliferone.](ol-15-05-6297-g02){#f3-ol-0-0-8147}

![Alterations in the migration of pancreatic ductal adenocarcinoma cells in the co-culture system following treatment with 4-MU using a Transwell migration assay. (A) Photomicrographs of migrating cells on the underside of chambers (magnification, ×400). Migrating cells penetrated onto the lower surface of the membrane and were fixed with 70% methanol, stained with hematoxylin and eosin, and air-dried. (B) Panc-1 cell migration was inhibited by 4-MU in a dose-dependent manner (\*\*\*P\<0.001, one-way analysis of variance and Fisher\'s least significant difference test). Results are presented as the mean ± standard deviation of six replicates. HA, hyaluronan; 4-MU, 4-methylumbelliferone.](ol-15-05-6297-g03){#f4-ol-0-0-8147}
